Henry Schein (NASDAQ:HSIC) Issues FY24 Earnings Guidance

Henry Schein (NASDAQ:HSIC) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided EPS guidance of $5.00 to $5.16 for the period, compared to the consensus EPS estimate of $5.06. The company issued revenue guidance of +8-10% yr/yr or $13.326 billion to $13.573 billion from +8, compared to the consensus revenue estimate of $13.42 billion.

Henry Schein Trading Up 4.2 %

Shares of HSIC traded up $2.88 during mid-day trading on Tuesday, hitting $71.41. The company had a trading volume of 1,561,488 shares, compared to its average volume of 1,092,228. The business’s 50-day simple moving average is $73.22 and its 200-day simple moving average is $72.32. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. Henry Schein has a 1-year low of $60.01 and a 1-year high of $82.63. The stock has a market cap of $9.17 billion, a PE ratio of 21.76, a P/E/G ratio of 1.68 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.21 billion. During the same period last year, the company earned $1.21 earnings per share. The company’s quarterly revenue was up 3.7% on a year-over-year basis. Sell-side analysts forecast that Henry Schein will post 5.07 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. JPMorgan Chase & Co. lifted their price target on shares of Henry Schein from $82.00 to $88.00 and gave the company an overweight rating in a research report on Wednesday, March 6th. SVB Leerink started coverage on shares of Henry Schein in a research report on Monday, February 26th. They set a market perform rating and a $78.00 target price on the stock. Leerink Partnrs reissued a market perform rating on shares of Henry Schein in a research report on Monday, February 26th. Piper Sandler boosted their target price on shares of Henry Schein from $78.00 to $86.00 and gave the stock an overweight rating in a research report on Monday, February 26th. Finally, Evercore ISI lifted their price target on shares of Henry Schein from $79.00 to $83.00 and gave the stock an in-line rating in a research note on Wednesday, February 28th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of Hold and a consensus price target of $81.09.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the company’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the transaction, the insider now owns 209,562 shares in the company, valued at $15,585,125.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Bradford C. Connett sold 6,430 shares of the company’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.